Document is current
Any future updates will be listed below
-
Authors
Altmann, Daniel M. https://orcid.org/0000-0002-2436-6192
Reynolds, Catherine J.
Joy, George
Otter, Ashley D. https://orcid.org/0000-0002-8317-9194
Gibbons, Joseph M. https://orcid.org/0000-0002-7238-2381
Pade, Corinna
Swadling, Leo https://orcid.org/0000-0002-0537-6715
Maini, Mala K. https://orcid.org/0000-0001-6384-1462
Brooks, Tim https://orcid.org/0000-0002-3783-1284
Semper, Amanda
McKnight, Áine
Noursadeghi, Mahdad https://orcid.org/0000-0002-4774-0853
Manisty, Charlotte https://orcid.org/0000-0003-0245-7090
Treibel, Thomas A.
Moon, James C.
,
Boyton, Rosemary J. https://orcid.org/0000-0002-5608-0797
-
Funding
Funding for this research was provided by:
RCUK | Medical Research Council (MR/W020610/1, MR/W020610/1, MR/W020610/1, MR/W020610/1, MR/W020610/1)
- License Information
-
More Information
Article History
Received: 30 November 2022
Accepted: 27 July 2023
First Online: 23 August 2023
Competing interests
: R.J.B. and D.M.A. are members of the Global T cell Expert Consortium and have consulted for Oxford Immunotec outside the submitted work. DMA has received honorarium payments from Pfizer, AstraZeneca and Novavax for consultancy work. The remaining authors declare no competing interests.
